Back to Capital Research Global Investors Capital Research Global Investors

ALNYALNY
Showing 8 of 15 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in ALNYLAM PHARMACEUTICALS INC

Capital Research Global Investors holds 9.8M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $2.9B as of 2026-Q2. The position was increased (+3.0% shares). ALNY represents 0.4% of Capital Research Global Investors's portfolio.

Current Value

$2.9B

Current Shares

9.8M

Total Value Change

+$1.5B

Total Shares Change

+4.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.8M
+3.0%
$2.9B0.4%$301.03
39
2026-Q1
Increased
9.5M
+39.7%
$3.1B0.5%$330.87
51
2025-Q4
Decreased
6.8M
-6.1%
$2.7B0.5%$397.65
0
2025-Q3
Increased
7.2M
+0.4%
$3.3B0.6%$456.00
45
2025-Q2
Increased
7.2M
+0.5%
$2.3B0.5%$326.09
38
2025-Q1
Increased
7.2M
+2.7%
$1.9B0.4%$270.02
39
2024-Q4
Increased
7M
+32.9%
$1.6B0.3%$235.31
49
2024-Q3
Increased
5.2M
+61.1%
$1.4B0.3%$275.03
55

Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used